1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment | Patent Number 09227946

US 09227946 B2
Application Number14242337
Publication NumberUS 20140248355 A1
Pendency1 year, 9 months, 9 days
Filled DateApr 1, 2014
Priority DateJun 16, 2006
Publication DateSep 4, 2014
Expiration DateJun 15, 2026
Inventor/ApplicantsRene Holm
Andre Faldt
Heidi Lopez de Diego
ExaminesPOLANSKY, GREGG
Art Unit1621
Technology Center1600
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.